Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10916072 | Nuclear Medicine and Biology | 2013 | 5 Pages |
Abstract
In mice with PC3 PCa xenografts, acute administration of Acipimox increases tumor uptake of 18Â F-FDG with general improvements in tumor-to-background ratios. Data indicate that administration of Acipimox prior to 18Â F-FDG PET scans has potential to improve sensitivity and specificity in patients with castration-resistant advanced PCa.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Kim Francis Andersen, Vadim Divilov, Jacek Koziorowski, NagaVaraKishore Pillarsetty, Jason S. Lewis,